Barrett's esophagus other imaging findings: Difference between revisions

Jump to navigation Jump to search
Anmol Pitliya (talk | contribs)
No edit summary
Hamid Qazi (talk | contribs)
No edit summary
Line 2: Line 2:
{{Barrett's esophagus}}
{{Barrett's esophagus}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{HQ}}


==Overview==
==Overview==
Line 12: Line 12:


==Other Imaging Findings==
==Other Imaging Findings==
*There are no other imaging findings associated with [disease name].
===UNSEDATED ESOPHAGOSCOPY===
 
*Using local anesthesia with aerosolized 4% lidocaine and oxymetazoline hydrochlorine a small-caliber upper endoscope passed transorally or transnasally into the esophagus with topical anesthesia
*[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include:
*We use an atomizer to instill 7 mL of aerosolized 4% lidocaine and 0.05% oxymetazoline hydrochloride into the patent nares over five minutes.  
**[Finding 1]
*Next, we administer a 3-second instillation of aerosolized 14% benzocaine into the oropharynx.
**[Finding 2]
*We then have the patient put their chin to their chest and pass a 4.9 mm diameter flexible endoscope with a 2 mm working channel transnasally through the nasal turbinates and into the oropharynx, hypopharynx, esophagus, and stomach.
**[Finding 3]
*We have found that the 5 mm caliber scope that we use remains tolerable and allows for biopsies to be taken at the time of unsedated exam, obviating the need for sedated EGD if non-dysplastic BE is discovered.


==References==
==References==

Revision as of 21:21, 4 February 2018

Barrett's Esophagus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Barrett's Esophagus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Endoscopic Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Barrett's esophagus other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Barrett's esophagus other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Barrett's esophagus other imaging findings

CDC on Barrett's esophagus other imaging findings

Barrett's esophagus other imaging findings in the news

Blogs on Barrett's esophagus other imaging findings

Directions to Hospitals TreatingBarrett's esophagus

Risk calculators and risk factors for Barrett's esophagus other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Imaging Findings

UNSEDATED ESOPHAGOSCOPY

  • Using local anesthesia with aerosolized 4% lidocaine and oxymetazoline hydrochlorine a small-caliber upper endoscope passed transorally or transnasally into the esophagus with topical anesthesia
  • We use an atomizer to instill 7 mL of aerosolized 4% lidocaine and 0.05% oxymetazoline hydrochloride into the patent nares over five minutes.
  • Next, we administer a 3-second instillation of aerosolized 14% benzocaine into the oropharynx.
  • We then have the patient put their chin to their chest and pass a 4.9 mm diameter flexible endoscope with a 2 mm working channel transnasally through the nasal turbinates and into the oropharynx, hypopharynx, esophagus, and stomach.
  • We have found that the 5 mm caliber scope that we use remains tolerable and allows for biopsies to be taken at the time of unsedated exam, obviating the need for sedated EGD if non-dysplastic BE is discovered.

References

Template:WH Template:WS